Local Host Partner
A*STAR x Nucleic Acid Therapeutics Initiative (NATi)
Profile
The Nucleic Acid Therapeutics Initiative (NATi) is a national platform that aims to build Singapore into a regional hub for nucleic acid therapeutics (NAT) research, clinical translation, and commercialisation.
NATi harnesses the potential of nucleic acids to treat diseases using RNA molecules. This initiative bolsters strategic partnerships and propels healthcare innovations, benefiting Singapore and Singaporeans.
We're bringing you
Keynote Address: Insights into Singapore's journey in mRNA innovation
, 8:45amView SessionDriving Innovation for the Next-Generation RNA Therapeutics in the Asia-Pacific Region
, 9:35amView SessionThink Like Resistant Cancer: Turning Tumor RNA Adaptations into Targeted Therapeutics
, 12:05pmView SessionKeynote Address: NATi: Driving Innovation and Translation in RNA Medicine
, 9:05amView SessionRNA Secondary Structures: Connecting Viral Genomes to mRNA Therapeutics
, 12:50pmView Session